HYDROXYCHLOROQUINE SULFATE
- Product NDC
- 71337-019
- 11-digit product format
- 713370019
- Labeler code
- 71337
- Product ID
- 71337-019_66d9da43-72d1-4117-8708-9c27d97b8cac
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- hydroxychloroquine sulfate
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Havix Group Inc d-b-a Aavis Pharmaceuticals
- Application
- ANDA212902
- Marketing category
- ANDA
- Marketing start
- 2020-08-13
- Marketing end
- 0000-00-00
- Substance
- HYDROXYCHLOROQUINE SULFATE
- Active strength
- 200 mg/1
- Pharmacologic classes
- Antirheumatic Agent [EPC],Antimalarial [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2021-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 71337-019-01 | 71337001901 | 100 TABLET in 1 BOTTLE (71337-019-01) | 100 tablet | 2020-08-14 | 0000-00-00 | No | No | Current |
| 71337-019-05 | 71337001905 | 500 TABLET in 1 BOTTLE (71337-019-05) | 500 tablet | 2020-08-14 | 0000-00-00 | No | No | Current |